Annual ROE
8.41%
-3.16%-27.31%
December 31, 2024
Summary
- As of February 25, 2025, RPRX annual return on equity is 8.41%, with the most recent change of -3.16% (-27.31%) on December 31, 2024.
- During the last 3 years, RPRX annual ROE has risen by +2.26% (+36.75%).
- RPRX annual ROE is now -80.85% below its all-time high of 43.92%, reached on December 31, 2019.
Performance
RPRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
8.54%
-3.02%-26.12%
December 31, 2024
Summary
- As of February 25, 2025, RPRX quarterly return on equity is 8.54%, with the most recent change of -3.02% (-26.12%) on December 31, 2024.
- Over the past year, RPRX quarterly ROE has dropped by -3.08% (-26.51%).
- RPRX quarterly ROE is now -77.80% below its all-time high of 38.47%, reached on December 31, 2019.
Performance
RPRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RPRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.3% | -26.5% |
| 3 y3 years | +36.8% | -26.5% |
| 5 y5 years | -80.8% | -26.5% |
RPRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.3% | +1855.8% | -26.5% | +1933.3% |
| 5 y | 5-year | -80.8% | +1855.8% | -77.8% | +1933.3% |
| alltime | all time | -80.8% | +1855.8% | -77.8% | +1933.3% |
Royalty Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 8.41%(-27.3%) | 8.54%(-26.1%) |
| Sep 2024 | - | 11.56%(+68.5%) |
| Jun 2024 | - | 6.86%(-15.5%) |
| Mar 2024 | - | 8.12%(-30.1%) |
| Dec 2023 | 11.57%(+2590.7%) | 11.62%(+518.1%) |
| Sep 2023 | - | 1.88%(-26.3%) |
| Jun 2023 | - | 2.55%(-22.7%) |
| Mar 2023 | - | 3.30%(+685.7%) |
| Dec 2022 | 0.43% | 0.42%(-91.4%) |
| Sep 2022 | - | 4.91%(+8.6%) |
| Jun 2022 | - | 4.52%(-23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 5.90%(-3.3%) |
| Dec 2021 | 6.15%(-49.4%) | 6.10%(-21.6%) |
| Sep 2021 | - | 7.78%(-21.0%) |
| Jun 2021 | - | 9.85%(-6.6%) |
| Mar 2021 | - | 10.55%(-8.3%) |
| Dec 2020 | 12.16%(-72.3%) | 11.50%(-58.0%) |
| Sep 2020 | - | 27.38%(-11.6%) |
| Jun 2020 | - | 30.96%(-15.0%) |
| Mar 2020 | - | 36.44%(-5.3%) |
| Dec 2019 | 43.92%(+43.1%) | 38.47% |
| Dec 2018 | 30.70% | - |
FAQ
- What is Royalty Pharma annual return on equity?
- What is the all time high annual ROE for Royalty Pharma?
- What is Royalty Pharma annual ROE year-on-year change?
- What is Royalty Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Royalty Pharma?
- What is Royalty Pharma quarterly ROE year-on-year change?
What is Royalty Pharma annual return on equity?
The current annual ROE of RPRX is 8.41%
What is the all time high annual ROE for Royalty Pharma?
Royalty Pharma all-time high annual return on equity is 43.92%
What is Royalty Pharma annual ROE year-on-year change?
Over the past year, RPRX annual return on equity has changed by -3.16% (-27.31%)
What is Royalty Pharma quarterly return on equity?
The current quarterly ROE of RPRX is 8.54%
What is the all time high quarterly ROE for Royalty Pharma?
Royalty Pharma all-time high quarterly return on equity is 38.47%
What is Royalty Pharma quarterly ROE year-on-year change?
Over the past year, RPRX quarterly return on equity has changed by -3.08% (-26.51%)